| Aug 30 |
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
|
| Aug 30 |
2 Incredibly Cheap Healthcare Stocks to Buy Now
|
| Aug 29 |
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
|
| Aug 29 |
Why Is Pfizer (PFE) Down 5.9% Since Last Earnings Report?
|
| Aug 29 |
AbbVie: Promising Developments On IBD Treatments
|
| Aug 29 |
AbbVie Already Has The Next Humira
|
| Aug 29 |
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
|
| Aug 29 |
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
|
| Aug 28 |
AbbVie: Stunning Turnaround, But No Longer A Bargain (Rating Downgrade)
|
| Aug 28 |
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
|
